Where I see patients (4)
Selected research
-
Real-world effectiveness of ustekinumab and vedolizumab in TNF-exposed pediatric patients with ulcerative colitis.
Journal of pediatric gastroenterology and nutrition
-
Toxigenic Clostridium perfringens isolated from at-risk pediatric inflammatory bowel disease patients.
Journal of Crohn's & colitis
-
Evaluating the Relationship Between Nutrition and Post-colectomy Pouchitis in Pediatric Patients with Ulcerative Colitis.
Digestive diseases and sciences
Clinical trials
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulc...
Clinical Remission based on the MMS
Recruiting
More about this studyClinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
The achievement of complete healing (CH) 52 weeks after initiation of anti-TNF therapy guided by ROADMAB™ (therapeutic drug monitoring) as evidenced by a composite of all of the following four features below: Endoscopic healing (E...
Recruiting
More about this studyA Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Clinical response based on PCDAI, and endoscopic response based on SES-CD.
Recruiting
More about this studyA Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Act...
Recruiting
More about this studyA Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC...
Clinical remission based on the modified Mayo score is defined as stool frequency subscore 0 to 1 and a decrease of 1 or more from Baseline; rectal bleeding subscore of 0; and, endoscopy subscore 0 to 1 (modified so that a score o...
Recruiting
More about this studyA Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Clinical remission is defined by PCDAI score ≤10. The PCDAI was specifically designed for use in children. The PCDAI includes a child-specific item: the height velocity variable as well as three laboratory parameters: hematocrit (...
Recruiting
More about this studyPersonalized AZithromycin/metronidAZole Therapy in Pediatric Crohn's Disease (CD)
Subjects without need for re-induction for clinical flare (new course of nutritional therapy, need to restart steroids), steroid dependence, biologic (e.g. anti-TNF) use, and/or intestinal surgery
Recruiting
More about this studyContact me
Fetal surgery firsts